NCT03678883: 9-ING-41 in Patients With Advanced Cancers
- State
- Under way
- Phase
- Phase 2
- People
- 350 planned
- Started
- 4 Jan 2019
- Primary completion
- Jun 2026
- Arms
- 9-ING-41
- Results
- None posted
- 20 Sep 2018: Trial registered
- 4 Jan 2019: Trial started
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.
Kind of treatment: Drug.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.